Antigen-directed therapies: an effective tool in acute myeloid leukemia?
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.|Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.|Department of Epidemiology, University of Washington, Seattle, WA, USA.
Roland B
RB
Walter
D000617:Aminoglycosides; D061067:Antibodies, Monoclonal, Humanized; D000951:Antigens, Neoplasm; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D000079982:Gemtuzumab; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D058990:Molecular Targeted Therapy / Q000379:methods*
D000617:Aminoglycosides; D061067:Antibodies, Monoclonal, Humanized; D000951:Antigens, Neoplasm; D000074322:Antineoplastic Agents, Immunological; D000079982:Gemtuzumab
CD33; acute myeloid leukemia; antibody; antigen; gemtuzumab ozogamicin; immunotherapy